X7 Research performs bioequivalence studies of medicinal products by current regulations in Russia, EAEU, CIS, EU. This procedure is the main biomedical control procedure for generics. Clinical trials are conducted in the shortest time possible and within the allocated budget.
X7 Research offers its clients full accompaniment and support at all stages of generics marketing in the chosen country.
SUPPORT AT ALL STAGES OF STUDY
AVAILABILITY OF OWN CLINICAL SITE.
The team of professionals at X7 Research has decades of experience in conducting bioequivalence studies. With our help, the report will successfully pass all the necessary approvals and the drug will be introduced even to the most strictly regulated market.